Business Context and Reporting Period
Company: Kewaunee Scientific Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: October 31, 2010 (Second Quarter of Fiscal Year 2011)
Business Overview: The Company manufactures and sells laboratory furniture and equipment. It operates through Domestic and International segments. The Company is classified as a smaller reporting company.
Key Financial Metrics
| Metric (in thousands) | 3 Months Ended Oct 31, 2010 | 6 Months Ended Oct 31, 2010 |
|---|---|---|
| Net Sales | $25,625 | $50,483 |
| Gross Profit | $5,417 | $10,416 |
| Gross Margin | 21.1% | 20.6% |
| Operating Earnings | $1,372 | $2,470 |
| Net Earnings (Attributable to Kewaunee) | $855 | $1,512 |
| Diluted EPS | $0.33 | $0.59 |
| Cash from Operations (6 months) | $479 | |
| Working Capital | $21,781 (as of Oct 31, 2010) | |
| Total Debt (Bank Borrowings + Leases) | $8,273 (as of Oct 31, 2010) |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 5% for both the three and six-month periods compared to the prior year. Domestic sales declined due to softness in the marketplace for small and mid-sized laboratory projects, while international sales increased.
- Margin Compression: Gross profit margins decreased to 21.1% (Q2) and 20.6% (YTD) from 22.9% and 22.4% in the prior year, driven by aggressive pricing and lower production volumes.
- Earnings Decline: Net earnings attributable to the Company dropped 37% for the quarter and 38% for the six-month period compared to the prior year.
- Increased Interest Expense: Interest expense rose to $77,000 (Q2) and $122,000 (YTD) from $39,000 and $80,000 in the prior year due to higher bank borrowings.
- Order Backlog: The order backlog was $66.0 million at October 31, 2010, a slight decrease from $66.9 million at July 31, 2010, but an increase from $65.2 million at October 31, 2009.
Guidance, Outlook, and Risks
- Outlook: Management expects sales and earnings for the second half of fiscal year 2011 to likely improve over the first half. This expectation is based on scheduled deliveries from the order backlog, a modest global economic recovery, and increased international sales opportunities.
- Capital Expenditures: The Company incurred $3.7 million in capital expenditures for the six months ended October 31, 2010, primarily to fund the expansion of its Statesville, North Carolina manufacturing facilities.
- Debt Financing: In August 2010, the Company secured a $4 million seven-year term loan (secured by real property and equipment) to fund facility expansion. An interest rate swap was entered into to fix the rate at 4.875%.
- Risks: Future demand is difficult to predict due to the Company's role as a subcontractor/supplier and dependence on laboratory construction projects. Risks include economic factors, raw material prices, and energy costs.
Investor Verification Checklist
- Domestic Market Recovery: Verify if the "softness" in the domestic marketplace for small/mid-sized projects is stabilizing, as this was the primary driver of revenue decline.
- Pricing Power: Assess whether the Company can reverse the trend of "aggressive pricing" without further eroding gross margins.
- Debt Servicing: Confirm the impact of the new $4 million term loan and increased interest expense on future cash flows and liquidity.
- Order Backlog Conversion: Monitor the conversion rate of the $66.0 million order backlog into recognized revenue in the upcoming quarters.
- International Growth: Evaluate the sustainability of the growth in international sales, which offset some domestic declines.